Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
- Resource Type
- Article
- Source
- The Lancet Diabetes & Endocrinology; July 2019, Vol. 7 Issue: 7 p515-527, 13p
- Subject
- Language
- ISSN
- 22138587; 22138595